首页> 外文期刊>Reumatismo >Adherence to therapeutic and diagnostic recommendations in patients with femur fracture and at risk of re-fracture or death: results of an analysis of administrative databases
【24h】

Adherence to therapeutic and diagnostic recommendations in patients with femur fracture and at risk of re-fracture or death: results of an analysis of administrative databases

机译:坚持股骨骨折并有再次骨折或死亡风险的患者的治疗和诊断建议:行政数据库分析的结果

获取原文
获取外文期刊封面目录资料

摘要

The aim of the present study was to evaluate the application into clinical practice of therapeutic and diagnostic recommendations for the prevention of bone re-fracture in postmenopausal women after an hospitalization for hip fracture in clinical practice and to assess the relationship between the application of diagnostic recommendations and re-fracture or death risk. A retrospective cohort analysis was conducted. All female patients, at least 65 years old, and with an hospitalization with main or secondary diagnosis of hip fracture during the period 1 January 2006 – 31 December 2008, were included. Besides demographic characteristics and comorbidities, drug treatment prescriptions related to bone fracture or supplementary with calcium or vitamin D and prescriptions of recommended laboratory and instrumental diagnostic tests (e.g. spine radiography), were analysed. A total of 5,636 patients were included in the study. The prescription of a drug treatment aimed to reduce the risk of re-fracture was found in 16.3% of patients, among them 76.3% (699 patients) used bisphosphonates only, 17.1% (157 patients) strontium ranelate only and 4.9% (45 patients) used more than one treatment during the observation period. Among the patients who did not receive drug treatment, 17.5% made use of only supplemental calcium and vitamin D. The remaining part of patients (69.1%) received no treatment. The prescription of at least one laboratory test of first and second level was performed, respectively, on 53.7% and 43.1% of included patients, whereas the prescription of at least one instrumental test of first and second level was performed, respectively, on 5.9% and 0.8%. Although it is established that the prescription of the recommended tests and appropriate drug treatment are significantly associated with reduced risk of re-fracture and death, today the application of these recommendations is reduced.
机译:本研究的目的是评估治疗和诊断建议在临床实践中的应用,以预防绝经后妇女因髋部骨折住院治疗后骨再骨折的临床实践,并评估诊断建议之间的关系。再骨折或死亡风险。进行了回顾性队列分析。所有女性患者,年龄至少65岁,在2006年1月1日至2008年12月31日期间住院,主要或次要诊断为髋部骨折。除了人口统计学特征和合并症外,还分析了与骨折或补充钙或维生素D有关的药物治疗处方以及推荐的实验室和仪器诊断测试(例如脊柱放射照相)的处方。该研究共纳入5636名患者。在16.3%的患者中发现了旨在降低再次骨折风险的药物治疗处方,其中仅76.3%(699例患者)使用双膦酸盐,17.1%(157例患者)雷奈酸锶和4.9%(45例患者) )在观察期内使用了不止一种治疗方法。在未接受药物治疗的患者中,有17.5%仅使用补充钙和维生素D。其余患者(69.1%)未接受任何治疗。分别对53.7%和43.1%的患者进行了至少一项第一级和第二级实验室测试的处方,而分别对5.9%的第一级和第二级仪器测试进行了处方。和0.8%。尽管已经确定建议的测试处方和适当的药物治疗与降低再次骨折和死亡的风险显着相关,但如今减少了这些建议的应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号